ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016)
ENDRA Life Sciences (NDRA) reported Amortization of Deferred Charges of $338164.0 for Q4 2016, down 2.3% quarter-over-quarter from $346119.0 in Q3 2016.
ENDRA Life Sciences (NDRA) Amortization of Deferred Charges (2016) Analysis & Trends
ENDRA Life Sciences (NDRA) has 1 years of Amortization of Deferred Charges data on file, last reported at $338164.0 in Q4 2016.
- Amortization of Deferred Charges for Q4 2016 came in at $338164.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $684283.0 (changed N/A YoY), and the FY2020 annual result was $232426.0, down 90.13% from the prior year.
- Amortization of Deferred Charges slipped to $338164.0 in Q4 2016 per NDRA's latest filing, from $346119.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $346119.0 in Q3 2016 and troughed at $338164.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 338,164.00 |
| Dec 31, 2016 | 338,164.00 |
| Sep 30, 2016 | 346,119.00 |
| Sep 30, 2016 | 346,119.00 |